Search

Your search keyword '"Cannata Ortiz, P."' showing total 99 results

Search Constraints

Start Over You searched for: Author "Cannata Ortiz, P." Remove constraint Author: "Cannata Ortiz, P."
99 results on '"Cannata Ortiz, P."'

Search Results

1. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy

2. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

6. Positive/retained SDHB immunostaining in renal cell carcinomas associated to germline SDHB-deficiency: case report

7. Osteoporosis management in hematologic stem cell transplant recipients: Executive summary

9. Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension

10. The MEST score provides earlier risk prediction in lgA nephropathy

12. Histone lysine crotonylation during acute kidney injury in mice

13. Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)

16. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

17. Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats.

18. Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experience

19. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

20. CTGF deficiency predisposes to aneurysm generation and rupture. Mineralocorticoid antagonist as potential therapeutic treatment.

21. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

22. First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group

23. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

24. Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine.

25. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients

26. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool

27. CCN2 (Cellular Communication Network Factor 2) Deletion Alters Vascular Integrity and Function Predisposing to Aneurysm Formation.

28. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort

29. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort

30. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

31. Reproducibility of the Oxford Classification of IgA nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALIGA study cohort

32. Bone Marrow?Derived RIPK3 Mediates Kidney Inflammation in Acute Kidney Injury

33. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

34. Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy

37. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy

40. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

41. Histone lysine crotonylation during acute kidney injury in mice

42. The transcription factor Fosl1 preserves Klotho expression and protects from acute kidney injury

43. The MEST score provides earlier risk prediction in lgA nephropathy

44. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery

45. Osteoporosis management in hematologic stem cell transplant recipients: Executive summary.

46. Validation of a Histologic Scoring Index for C3 Glomerulopathy

47. Bcl3: a regulator of NF-κB inducible by TWEAK in acute kidney injury with anti-inflammatory and antiapoptotic properties in tubular cells

48. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.

49. Liposomal Doxorubicin in Aggressive B Cell Lymphoma Has Similar Efficacy to the Conventional Formulation: Results from a Retrospective Cohort Study

Catalog

Books, media, physical & digital resources